Drug manufacturers are working on the next wave of GLP-1 drugs after the success of others like Ozempic and Wegovy. NBC News’ Berkeley Lovelace Jr. has details on how these new versions may go beyond diabetes and weight loss. NBC News Health
Drug manufacturers are working on the next wave of GLP-1 drugs after the success of others like Ozempic and Wegovy. NBC News’ Berkeley Lovelace Jr. has details on how these new versions may go beyond diabetes and weight loss.
